Dove soap maker Unilever signals pursuit of GSK consumer arm; shares fall

  • 📰 Reuters
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

WATCH: Unilever will pursue a deal for GlaxoSmithKline's consumer healthcare business which comes after GSK confirmed over the weekend it had rejected a $68 billion offer, which it said 'fundamentally undervalued' the unit

to review Unilever's approach but it will not engage in talks unless Unilever bumps up its offer, sources familiar with the matter said.GSK's shares jumped 6% to their highest level since May 2020. It said on Saturday Unilever's proposal "fundamentally undervalued" the consumer business, adding that it would stick to its plan of listing the division this year.

The Marmite spread maker, however, defended the bid for the GSK consumer business, in which U.S. drugs company Pfizer"The acquisition would create scale and a growth platform for the combined portfolio in the U.S., China and India, with further opportunities in other emerging markets," Unilever said, pointing to synergies in the oral care and vitamin supplements business.

The source called the business a "legitimate standalone candidate", adding its market value could rise to almost $100 billion once the business was spun out and listed.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Viewsroom: Credit Suisse chair, Unilever’s GSK bidAs António Horta-Osório quits the Swiss lender after less than a year, Liam Proud explains what happened and offers career advice. And Unilever’s 50 bln pound offer for the pharma giant’s consumer unit puts both CEOs on the spot, say Aimee Donnellan and Dasha Afanasieva.
Source: Reuters - 🏆 2. / 97 Read more »

Viewsroom: Credit Suisse chair, Unilever’s GSK bidAs António Horta-Osório quits the Swiss lender after less than a year, Liam Proud explains what happened and offers career advice. And Unilever’s 50 bln pound offer for the pharma giant’s consumer unit puts both CEOs on the spot, say Aimee Donnellan and Dasha Afanasieva.
Source: Reuters - 🏆 2. / 97 Read more »

What Is Fantom Maker (FAME)? A Democratic Launchpad for Fantom | CoinMarketCap.CMCAlexandria dives into Fantommaker, a launchpad and incubator primarily focused on the Fantom blockchain. As part of the TheDaoMaker ecosystem, Fantom Maker looks to add some rocket fuel to the Fantom ecosystem. 👇 CMCAlexandria FantomMaker TheDaoMaker Lots of great coins are going to explode this year. Floki, Baby Doge, Evergrow and Saitama.. Kudos to these projects . But very few great coins are still early enough to go 10,000x. GreenChartBSC is one of the few. 3 weeks old and everything is in place to break records. CMCAlexandria FantomMaker TheDaoMaker GameVerseBSC 🎮Free to play P2E 💵Pays in BNB 🕹️ PlayToEarn app this month 📈Profit Sharing 🔥CMC & CG Listed Day1 😎Doxxed devs 🧾 Registered Company 🔒Liquidity 1 year 🚀Long term Utility 💯SAFU! 💎 LowCapGems GameVerse GameFi Launchpad Crypto gaming Metaverse GMV CMCAlexandria FantomMaker TheDaoMaker BabyDogeCoin
Source: CoinMarketCap - 🏆 290. / 63 Read more »

Is Wellness Culture Making Us Worse Friends?Professor and author CederstromCarl shares with us how the individual focus of wellness might be harming us in unexpected ways.
Source: NylonMag - 🏆 697. / 51 Read more »

Peloton Shares Fall on Report of Company Halting ProductionShares of Peloton sank Thursday following a report that said the company is halting production on its connected-fitness products CEO comments: 'As we discussed last quarter, we are taking significant corrective actions to improve our profitability outlook and optimize our costs across the company. This includes gross margin improvements, moving to a more variable cost structure…” Dang! The first time I saw this, it was Enron. Might as well AMCSTOCK since couch potatoes save lives.
Source: WSJ - 🏆 98. / 63 Read more »